vs
Amphastar Pharmaceuticals, Inc.（AMPH）とWD 40 CO（WDFC）の財務データ比較。上の社名をクリックして会社を切り替えられます
Amphastar Pharmaceuticals, Inc.の直近四半期売上が大きい（$183.1M vs $154.4M、WD 40 COの約1.2倍）。Amphastar Pharmaceuticals, Inc.の純利益率が高く（13.3% vs 11.3%、差は2.0%）。WD 40 COの前年同期比売上増加率が高い（0.6% vs -1.8%）。Amphastar Pharmaceuticals, Inc.の直近四半期フリーキャッシュフローが多い（$24.6M vs $9.1M）。過去8四半期でWD 40 COの売上複合成長率が高い（5.4% vs 3.2%）
Amphastar Pharmaceuticalsは上場されている米国の特殊製薬企業です。2004年5月に設立され、主に吸入剤および鼻腔内投与製品の開発、生産、販売を行っており、特色ある医薬品分野で事業を展開しています。
WD-40カンパニーは同名の多目的防錆潤滑剤で広く知られる世界的な消費財・産業用資材メーカーです。洗浄剤、脱脂剤、特殊潤滑剤などの製品を取り扱い、170カ国以上の小売、産業、自動車分野の市場に商品を提供しています。
AMPH vs WDFC — 直接比較
売上が大きい
AMPH
1.2倍大きい
$154.4M
売上成長率が高い
WDFC
+2.4%の差
-1.8%
純利益率が高い
AMPH
純利益率が2.0%高い
11.3%
フリーキャッシュフローが多い
AMPH
FCF $15.5M多い
$9.1M
2年売上CAGRが高い
WDFC
2年複合成長率
3.2%
損益計算書 — Q4 FY2025 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $183.1M | $154.4M |
| 純利益 | $24.4M | $17.5M |
| 粗利率 | 46.8% | 56.2% |
| 営業利益率 | 19.4% | 15.1% |
| 純利益率 | 13.3% | 11.3% |
| 売上前年比 | -1.8% | 0.6% |
| 純利益前年比 | -35.7% | -7.8% |
| EPS（希薄化後） | $0.51 | $1.28 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上AMPHWDFC
| Q4 25 | $183.1M | $154.4M | ||
| Q3 25 | $191.8M | $163.5M | ||
| Q2 25 | $174.4M | $156.9M | ||
| Q1 25 | $170.5M | $146.1M | ||
| Q4 24 | $186.5M | $153.5M | ||
| Q3 24 | $191.2M | $156.0M | ||
| Q2 24 | $182.4M | $155.0M | ||
| Q1 24 | $171.8M | $139.1M |
純利益AMPHWDFC
| Q4 25 | $24.4M | $17.5M | ||
| Q3 25 | $17.4M | $21.2M | ||
| Q2 25 | $31.0M | $21.0M | ||
| Q1 25 | $25.3M | $29.9M | ||
| Q4 24 | $38.0M | $18.9M | ||
| Q3 24 | $40.4M | $16.8M | ||
| Q2 24 | $37.9M | $19.8M | ||
| Q1 24 | $43.2M | $15.5M |
粗利率AMPHWDFC
| Q4 25 | 46.8% | 56.2% | ||
| Q3 25 | 51.4% | 54.7% | ||
| Q2 25 | 49.6% | 56.2% | ||
| Q1 25 | 50.0% | 54.6% | ||
| Q4 24 | 46.5% | 54.8% | ||
| Q3 24 | 53.3% | 54.1% | ||
| Q2 24 | 52.2% | 53.1% | ||
| Q1 24 | 52.4% | 52.4% |
営業利益率AMPHWDFC
| Q4 25 | 19.4% | 15.1% | ||
| Q3 25 | 13.2% | 17.1% | ||
| Q2 25 | 24.2% | 17.4% | ||
| Q1 25 | 21.9% | 15.9% | ||
| Q4 24 | 24.2% | 16.4% | ||
| Q3 24 | 29.8% | 15.4% | ||
| Q2 24 | 30.3% | 17.5% | ||
| Q1 24 | 27.9% | 15.1% |
純利益率AMPHWDFC
| Q4 25 | 13.3% | 11.3% | ||
| Q3 25 | 9.0% | 13.0% | ||
| Q2 25 | 17.8% | 13.4% | ||
| Q1 25 | 14.8% | 20.4% | ||
| Q4 24 | 20.4% | 12.3% | ||
| Q3 24 | 21.1% | 10.8% | ||
| Q2 24 | 20.8% | 12.8% | ||
| Q1 24 | 25.1% | 11.2% |
EPS（希薄化後）AMPHWDFC
| Q4 25 | $0.51 | $1.28 | ||
| Q3 25 | $0.37 | $1.57 | ||
| Q2 25 | $0.64 | $1.54 | ||
| Q1 25 | $0.51 | $2.19 | ||
| Q4 24 | $0.74 | $1.39 | ||
| Q3 24 | $0.78 | $1.23 | ||
| Q2 24 | $0.73 | $1.46 | ||
| Q1 24 | $0.81 | $1.14 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $282.8M | $48.6M |
| 総負債低いほど良い | $608.7M | $85.7M |
| 株主資本純資産 | $788.8M | $264.1M |
| 総資産 | $1.6B | $459.7M |
| 負債/資本比率低いほどレバレッジが低い | 0.77× | 0.32× |
8四半期トレンド — 暦四半期で整列
現金・短期投資AMPHWDFC
| Q4 25 | $282.8M | $48.6M | ||
| Q3 25 | $276.2M | $58.1M | ||
| Q2 25 | $231.8M | $51.7M | ||
| Q1 25 | $236.9M | $53.0M | ||
| Q4 24 | $221.6M | $54.9M | ||
| Q3 24 | $250.5M | $46.7M | ||
| Q2 24 | $217.8M | $45.3M | ||
| Q1 24 | $289.6M | $55.4M |
総負債AMPHWDFC
| Q4 25 | $608.7M | $85.7M | ||
| Q3 25 | $608.6M | $86.2M | ||
| Q2 25 | $607.7M | $85.6M | ||
| Q1 25 | $603.9M | $84.4M | ||
| Q4 24 | $601.6M | $84.6M | ||
| Q3 24 | $596.4M | $86.0M | ||
| Q2 24 | $586.9M | $85.5M | ||
| Q1 24 | $594.0M | $85.9M |
株主資本AMPHWDFC
| Q4 25 | $788.8M | $264.1M | ||
| Q3 25 | $776.7M | $268.2M | ||
| Q2 25 | $757.5M | $257.1M | ||
| Q1 25 | $751.3M | $242.1M | ||
| Q4 24 | $732.3M | $226.3M | ||
| Q3 24 | $727.7M | $230.5M | ||
| Q2 24 | $713.3M | $222.2M | ||
| Q1 24 | $672.4M | $216.3M |
総資産AMPHWDFC
| Q4 25 | $1.6B | $459.7M | ||
| Q3 25 | $1.7B | $475.8M | ||
| Q2 25 | $1.6B | $456.0M | ||
| Q1 25 | $1.6B | $458.3M | ||
| Q4 24 | $1.6B | $447.3M | ||
| Q3 24 | $1.5B | $449.0M | ||
| Q2 24 | $1.5B | $443.6M | ||
| Q1 24 | $1.6B | $442.0M |
負債/資本比率AMPHWDFC
| Q4 25 | 0.77× | 0.32× | ||
| Q3 25 | 0.78× | 0.32× | ||
| Q2 25 | 0.80× | 0.33× | ||
| Q1 25 | 0.80× | 0.35× | ||
| Q4 24 | 0.82× | 0.37× | ||
| Q3 24 | 0.82× | 0.37× | ||
| Q2 24 | 0.82× | 0.38× | ||
| Q1 24 | 0.88× | 0.40× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $32.9M | $10.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $24.6M | $9.1M |
| FCFマージンFCF / 売上 | 13.4% | 5.9% |
| 設備投資強度設備投資 / 売上 | 4.5% | 0.6% |
| キャッシュ転換率営業CF / 純利益 | 1.35× | 0.57× |
| 直近12ヶ月FCF直近4四半期 | $121.2M | $78.2M |
8四半期トレンド — 暦四半期で整列
営業キャッシュフローAMPHWDFC
| Q4 25 | $32.9M | $10.0M | ||
| Q3 25 | $52.6M | $29.9M | ||
| Q2 25 | $35.6M | $35.1M | ||
| Q1 25 | $35.1M | $8.0M | ||
| Q4 24 | $29.0M | $14.9M | ||
| Q3 24 | $60.0M | $27.2M | ||
| Q2 24 | $69.1M | $19.9M | ||
| Q1 24 | $55.3M | $18.0M |
フリーキャッシュフローAMPHWDFC
| Q4 25 | $24.6M | $9.1M | ||
| Q3 25 | $47.2M | $28.6M | ||
| Q2 25 | $25.0M | $34.0M | ||
| Q1 25 | $24.4M | $6.6M | ||
| Q4 24 | $16.6M | $14.2M | ||
| Q3 24 | $46.2M | $26.4M | ||
| Q2 24 | $63.1M | $18.7M | ||
| Q1 24 | $46.5M | $16.7M |
FCFマージンAMPHWDFC
| Q4 25 | 13.4% | 5.9% | ||
| Q3 25 | 24.6% | 17.5% | ||
| Q2 25 | 14.3% | 21.6% | ||
| Q1 25 | 14.3% | 4.5% | ||
| Q4 24 | 8.9% | 9.3% | ||
| Q3 24 | 24.1% | 16.9% | ||
| Q2 24 | 34.6% | 12.0% | ||
| Q1 24 | 27.1% | 12.0% |
設備投資強度AMPHWDFC
| Q4 25 | 4.5% | 0.6% | ||
| Q3 25 | 2.8% | 0.8% | ||
| Q2 25 | 6.1% | 0.7% | ||
| Q1 25 | 6.3% | 0.9% | ||
| Q4 24 | 6.7% | 0.5% | ||
| Q3 24 | 7.2% | 0.5% | ||
| Q2 24 | 3.3% | 0.8% | ||
| Q1 24 | 5.1% | 0.9% |
キャッシュ転換率AMPHWDFC
| Q4 25 | 1.35× | 0.57× | ||
| Q3 25 | 3.03× | 1.41× | ||
| Q2 25 | 1.15× | 1.67× | ||
| Q1 25 | 1.39× | 0.27× | ||
| Q4 24 | 0.76× | 0.79× | ||
| Q3 24 | 1.48× | 1.62× | ||
| Q2 24 | 1.82× | 1.00× | ||
| Q1 24 | 1.28× | 1.16× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AMPH
| Other Products | $62.4M | 34% |
| Baqsimi | $46.7M | 26% |
| Primatenemist | $27.9M | 15% |
| Epinephrine | $17.1M | 9% |
| Lidocaine | $14.9M | 8% |
| Glucagon | $14.1M | 8% |
WDFC
| Other | $82.6M | 53% |
| WD40Multi Use Product | $56.0M | 36% |
| WD40Specialist | $9.0M | 6% |
| Other Maintenance Products | $4.0M | 3% |
| Homecare And Cleaning Products | $2.7M | 2% |
